Document:

EX-4.3

 Exhibit 4.3 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED (the “1933
ACT”), OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO YOU THAT SUCH
REGISTRATION IS NOT REQUIRED UNDER THE 1933 ACT, OR ANY APPLICABLE STATE SECURITIES LAWS. 
 PLAIN ENGLISH WARRANT AGREEMENT 

This is a PLAIN ENGLISH WARRANT AGREEMENT dated March 27, 2008 by and between AEROHIVE NETWORKS, INC., and TRIPLEPOINT CAPITAL LLC, a Delaware limited
liability company. 
 The words “We”, “Us”, or “Our” refer to the warrant holder, which is TRIPLEPOINT CAPITAL LLC. The words
“You” or “Your” refers to the issuer, which is AEROHIVE NETWORKS, INC., and not to any individual. The words “The Parties” refers to both TRIPLEPOINT CAPITAL LLC and AEROHIVE NETWORKS, INC. This Plain English Warrant
Agreement may be referred to as the “Warrant Agreement”. 
 The Parties have entered into a Plain English Growth Capital Loan and Security
Agreement dated as of March 27, 2008, the “Loan Agreement”, 
 In consideration of such Loan Agreement, the Parties agree to the following
mutual agreements and conditions set forth below: 
 WARRANT INFORMATION 

 

					
	 Effective Date
	 	 Warrant Number
	 	 Loan Facility Number

			
	March 27, 2008	 	0532-W-01	 	0532-GC-01

  

							
	 Warrant Coverage
	 	 Number of Shares
	 	 Price Per Share
	 	 Type of Stock

				
	 $80,000 (2% of $4,000,000);

up to an additional $80,000

(2% of any amounts advanced

under the Loan Agreement)
	 	 49,298; up to an additional

49,297 based upon any

amounts advanced under the

Loan Agreement
	 	$1.6228	 	Series B Preferred Stock

 OUR CONTACT INFORMATION 

 

					
	 Name
	  	 Address For Notices
	  	 Contact Person

			
	TriplePoint Capital LLC	  	 2755 Sand Hill Road, Ste. 150

Menlo Park, CA 94025
 Tel: (650)
854-2090
 Fax: (650) 854-1850
	  	Sajal Srivastava, COO

 YOUR
CONTACT INFORMATION 
  

					
	 Customer Name
	  	 Address For Notices
	  	 Contact Person

	Aerohive Networks, Inc.	  	 3150-C Coronado Drive

Santa Clara, CA 95054
	  	Seamus Hennessy, CFO

	1.	WHAT YOU AGREE TO GRANT US 

 You grant to Us and We are entitled, upon the terms and subject to the conditions
set forth in this Warrant Agreement, to purchase from You 49,298 fully paid and non-assessable shares of Your Warrant Stock at a purchase price equal to per share equal to the Exercise Price. 

In addition, You grant to Us and We are entitled, upon the terms and subject to the conditions set forth in this Warrant Agreement, to purchase from You, at a
price per share equal to the Exercise Price, an additional number of fully paid and non-assessable shares of Your Warrant Stock equal to two percent (2%) of any amounts advanced under the Loan Agreement. 

The number of shares of Warrant Stock and the Exercise Price of such Warrant Stock are subject to adjustment as provided in Section 4 hereof. 

For purposes of this Warrant Agreement, the following capitalized terms have the meanings given below: 

“Exercise Price” means the $1.6228. 

“Warrant Stock” means Your Series B Preferred Stock. 

The Parties agree that this Warrant Agreement to purchase the Warrant Stock has a fair market value equal to $100 and that $100 of the issue price of the
investment will be allocable to the Warrant Agreement and the balance shall be allocable to the Loan Agreement for income tax purposes and the original issue discount on the Loan Agreement shall be considered to be zero. 

 

	2.	WHEN ARE WE ENTITLED TO PURCHASE YOUR WARRANT STOCK. 

 The term of this Warrant Agreement and our right to
purchase Warrant Stock will begin the Effective Date, and shall be available for the lesser of (i) 10 years from the Effective Date or (ii) 1 year from the effective date of Your initial public offering. 

Notwithstanding the foregoing, Our right to purchase the Warrant Stock shall be automatically and fully exercised via the net issuance method described below
immediately prior to the effectiveness of a Merger Event, as defined below, with a Person that is not one of Your affiliates, in which Your common stock is exchanged for cash and/or stock that is traded on a recognized public exchange or on the
NASDAQ National Market, provided that upon consummation of the Merger Event, the consideration payable to Us pursuant to such exercise and on account of the Warrant Stock consists of (x) cash or (y) stock that is traded on a recognized
public exchange or on the NASDAQ National Market and the total per share consideration is equal to or greater than two (2) times the aggregate Exercise Price (as adjusted). In the event the stock consideration to be paid in (y) above is
less than two (2) times the aggregate Exercise Price (as adjusted) and We have not elected to exercise Our rights under this Warrant Agreement, then You may, at Your sole discretion, pay Us a sum equal to one (1) time the Exercise Price
for each share exercisable under this Warrant Agreement in exchange for the cancellation of this Warrant Agreement upon the consummation of such Merger Event, 

No less than ten (10) business days prior to any Merger Event, You shall provide Us with written notice of the proposed Merger Event together with a copy
of the executed merger agreement, or other definitive documentation (and all schedules and exhibits thereto) and information concerning Your expected capitalization immediately prior to the Merger Event. Upon consummation of the Merger Event, You
shall promptly provide Us with (a) a copy of any modifications or amendments to the executed merger agreement, (b) any other documents in connection therewith, (c) updated information, if any, concerning Your capitalization
immediately prior to the Merger Event, and, (d) upon request, by Us any other information reasonably necessary to an informed evaluation of Our rights under this Agreement. 

  
 -2- 

	3.	HOW WE MAY PURCHASE YOUR WARRANT STOCK. 

 We may exercise Our purchase rights, in whole or in part, at any time,
or from time to time, prior to the expiration of the term of this Warrant Agreement, by giving You a completed and executed Notice of Exercise in the form attached as Exhibit I. Promptly upon receipt of the Notice of Exercise and in any event no
later than twenty-one (21) days after you have received Our Notice of Exercise and payment of the aggregate Exercise Price for the shares purchased, You will issue to Us a certificate for the number of shares of Warrant Stock that We have
purchased and You will execute the Acknowledgment of Exercise in the form attached hereto as Exhibit II indicating the number of shares which will be available to Us for future purchases, if any. 

We may pay for the Warrant Stock by either (i) cash or check, or (ii) by the net issuance method as determined below. If We elect the Net Issuance
method, You will issue Warrant Stock using the following formula: 
  

							
	 X
	 	=	 	 Y(A-B)
	  	
		 		 	A	  	

  

							
	Where:	 	X	 	=	    	the number of shares of Warrant Stock to be issued to Us.
		 	Y	 	=	    	the number of shares of Warrant Stock We request to be exercised under this Warrant Agreement.
		 	A	 	=	    	the fair market value of one share of Warrant Stock.
		 	B	 	=	    	the Exercise Price.

 For purposes of the above calculation, current fair market value of Warrant Stock shall mean with respect to each share of
Warrant Stock: 
 If the exercise is in connection with the initial public offering of Your Common Stock, and if Your registration statement relating to
such public offering has been declared effective by the SEC, then the fair market value per share shall be the product of (x) the initial “Price to Public” specified in the final prospectus of the offering and (y) the number of
shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise; 
 If this Warrant Agreement is exercised after,
and not in connection with the Your initial public offering, and: 
  

	•	 	if traded on a securities exchange, the fair market value shall be the product of (x) the average of the closing prices over a five (5) day period ending three (3) days before the day the current fair
market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise; or 

 

	•	 	if actively traded over-the-counter, the fair market value shall be the product of (x) the average of the closing bid and asked prices quoted on the NASDAQ system (or similar system) over the five (5) day
period ending three (3) days before the day the current fair market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such
exercise. 

 If this Warrant Agreement is exercised prior to or after Your initial public offering, and: 

 

	•	 	Your Common Stock is not listed on any securities exchange or quoted in the NASDAQ System or the over-the-counter market, the current fair market value of Warrant Stock shall be the product of (x) the fair market
value of a share of Your Common Stock (the highest price per share which You could obtain from a willing buyer (not a current employee or director) for shares of Common Stock sold, from authorized but unissued shares), as determined in good faith by
Your Board of Directors and (y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise, unless You shall become subject to a merger, acquisition or other consolidation pursuant to
which You are not the surviving party, in which case the fair market value of Warrant Stock shall be deemed to be the value received by the holders of the Your Warrant Stock on a common equivalent basis pursuant to such merger or acquisition or
other consolidation. 

  
 -3- 

 During the term of this Warrant Agreement, You will at all times from and after the Effective Date have
authorized and reserved a sufficient number of shares of (a) Warrant Stock to provide for the exercise of our rights to purchase Warrant Stock, and (b) Common Stock to provide for the conversion of the Warrant Stock. 

If We elect to exercise part of the Warrant Agreement, You will promptly issue to Us an amended Warrant Agreement stating the remaining number of shares that
are available. All other terms and conditions of that amended Warrant Agreement shall be identical to those contained in this Warrant Agreement. 
 If at
the end of the term of this Warrant Agreement, the fair market value of one share of Warrant Stock (or other security issuable upon the exercise hereof) as determined in accordance herewith is greater than the Exercise Price in effect on such date,
then this Warrant Agreement shall automatically be deemed on and as of such date to be converted via the net issuance method described hereto as to all shares of Warrant Stock (or such other securities) for which it shall not previously have been
exercised or converted, and You shall promptly deliver a certificate representing the shares of Warrant Stock (or such other securities) issued upon such conversion to Us. 
  

	4.	WHEN WILL THE NUMBER OF SHARES AND EXERCISE PRICE CHANGE. 

  

	•	 	If You are Acquired. Subject to Section 2 hereto, if at any time; (i) there is a reorganization of Your stock (other than a reclassification, exchange or subdivision of Your stock otherwise provided for in
this Warrant Agreement); (ii) You merge or consolidate with or into another entity, whether or not You are the surviving entity; (iii) You sell or convey, or grant an exclusive license with respect to, all or substantially all of Your
assets to any other person; or (iv) there occurs any transaction or series of related transactions that result in the transfer of fifty percent (50%) or more of the outstanding voting power of the capital stock of You (each of the
foregoing events are referred to as a “Merger Event”), then, as a part of such Merger Event, lawful provision shall be made so that We shall thereafter be entitled to receive, upon exercise of Our rights under this Warrant Agreement, the
number of shares of preferred stock or other securities of the successor or surviving person resulting from such Merger Event, equal in value to that which would have been issuable if We had exercised Our rights under this Warrant Agreement
immediately prior to the Merger Event. In any such case, appropriate adjustment (as determined in good faith by the Your Board of Directors) shall be made in the application of the provisions of this Warrant Agreement with respect to Our rights and
interest after the Merger Event so that the provisions of this Warrant Agreement (including adjustments of the Exercise Price and number of shares of Warrant Stock purchasable) shall be applicable to the greatest extent possible. 

 

	•	 	If You Reclassify Your Stock. If at any time You combine, reclassify, exchange or subdivide Your securities or otherwise, change any of the securities as to which purchase rights under this Warrant Agreement exist into
the same or a different number of securities of any other class or classes, this Warrant Agreement will thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such change with
respect to the securities which were subject to the purchase rights under this Warrant Agreement immediately prior to such combination, reclassification, exchange, subdivision or other change. 

 

	•	 	If You Subdivide or Combine Your Shares. If at any time You combine or subdivide Your Series B Preferred Stock, the Exercise Price will be proportionately decreased in the case of a subdivision, or proportionately
increased in the case of a combination. 

  

	•	 	If You Pay Stock Dividends. If at any time You pay a dividend payable in, or make any other distribution (except any distribution specifically provided for in the above paragraphs) of Your Series B Preferred Stock, then
the Exercise Price shall be adjusted, from and after the record date of such dividend or distribution, to that price determined by multiplying the Exercise Price in effect immediately prior to such record date by a fraction (i) the numerator of
which shall be the total number of all shares of Your Series B Preferred Stock outstanding immediately prior to such dividend or distribution, and (ii) the denominator of which shall be the total number of all shares of Your Series B Preferred
Stock outstanding immediately after such dividend or distribution. We will thereafter be entitled to purchase, at the Exercise Price resulting from such adjustment, the number of shares of Warrant Stock (calculated to the nearest whole share)
obtained by multiplying the Exercise Price in effect immediately prior to such adjustment by the number of shares of Warrant Stock issuable upon the exercise hereof immediately prior to such adjustment and dividing the product thereof by the
Exercise Price resulting from such adjustment. 

  
 -4- 

	•	 	If You Change the Antidilution Rights of the Warrant Stock or Issue New Preferred or Convertible Stock. All antidilution rights applicable to the Warrant Stock purchasable under this Warrant Agreement are as set forth
in Your Certificate of Incorporation, as amended through the Effective Date. You will promptly provide Us with any restatement, amendment, modification of or waiver of any right under Your Certificate of Incorporation. You will provide Us with prior
written notice of any issuance of Your stock or other equity security to occur after the Effective Date (other than issuances of stock or equity securities pursuant to customary employee stock plans), which notice shall include (a) the price at
which such stock or security is to be sold, (b) the number of shares to be issued, and (c) such other information as necessary for Us to determine if a dilutive event has occurred or will occur as a result of such issuance.

  

	•	 	No Duplication of Adjustments. Notwithstanding anything to the contrary in this Warrant, nothing in this Warrant shall be deemed to duplicate adjustments to the number of Shares of Warrant stock issuable pursuant to
this Warrant, or the exercise price thereof, to the extent of adjustments made to stock of the same class and series as the Warrant Stock generally pursuant to the Company’s Certificate of Incorporation, as may be in effect from time to time.

  

	•	 	No Fractional Shares. We acknowledge that You will not issue fractional shares upon the exercise of this Warrant Agreement, in lieu of such fractional shares You will make a cash payment on the basis of the Exercise
Price then in effect. 

  

	5.	WE CAN TRANSFER THIS PLAIN ENGLISH WARRANT AGREEMENT. 

 Subject to the terms and conditions contained in
Section 7, We (or any successor transferee) may transfer in whole or in part this Warrant Agreement and all its rights. You will record the transfer on Your books when You receive Our Notice of Transfer in the form attached hereto as Exhibit
III, and Our payment of all transfer taxes and other governmental charges involved in such transfer. 
  

	6.	REPRESENTATEONS, WARRANTIES, AND COVENANTS FROM YOU. 

  

	•	 	Reservation of Warrant Stock. The Warrant Stock issuable upon exercise of Our rights under this Warrant Agreement will be duly and validly reserved and when issued in accordance with the provisions of this Warrant
Agreement will be validly issued, fully paid and non-assessable, and will be free of any taxes, liens, charges or encumbrances of any nature whatsoever; provided, however, that the Warrant Stock issuable pursuant to this Warrant Agreement may be
subject to restrictions on transfer under state and/or Federal securities laws. Upon Our exercise, You will issue to Us certificates for shares of Warrant Stock without charging Us any tax, or other cost incurred by You in connection with such
exercise and the related issuance of shares of Warrant Stock. You will not be required to pay any tax, which may be payable in respect of any transfer involved and the issuance and delivery of any certificate in a name other than TriplePoint Capital
LLC. 

  

	•	 	Due Authority. Your execution and delivery of this Warrant Agreement and the performance of Your obligations hereunder, including the issuance to Us of the right to acquire the shares of Warrant Stock, have been duly
authorized by all necessary corporate action on Your part and this Warrant Agreement is not inconsistent with Your Certificate of Incorporation or Bylaws, does not contravene any law or governmental rule, regulation or order applicable to it, do not
and will not contravene any provision of, or constitute a default under, any indenture, mortgage, contract or other instrument to which You are a party or by which You are bound, and this Warrant Agreement constitutes a legal, valid and binding
agreement, enforceable in accordance with its respective terms, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors and the rules of law or principles at equity governing specific performance,
injunctive relief and other equitable remedies. 

  

	•	 	 Consents and Approvals. No consent or approval of, giving of notice to, registration with, or taking of any other action in respect of any state,
Federal or other governmental authority or agency is required with respect to 

  
 -5- 

	 	 
execution, delivery and Your performance of Your obligations under this Warrant Agreement, except for the filing of any required notices pursuant to Federal and state securities laws, which
filings will be effective by the times required thereby. 

  

	•	 	Issued Securities. All of Your issued and outstanding shares of Common Stock, Warrant Stock or any other securities have been duly authorized and validly issued and are fully paid and nonassessable. All outstanding
shares of Common Stock and Warrant Stock were issued in full compliance with all Federal and state securities laws. In addition as of the Effective Date: 

Your authorized capital consists of (A) 43,300,000 shares of Common Stock, of which 13,923,574 shares of Common Stock are issued and outstanding, and
(B) 26,634,720 shares of preferred stock, of which 26,117,480 shares are issued and outstanding. 
 You have reserved 9,600,000 shares of Common Stock
for issuance under Your Stock Incentive Plan, under which 8,653,638 options have been granted. Except as otherwise provided in this Warrant Agreement and as noted above, there are no other options, warrants, conversion privileges or other rights
presently outstanding to purchase or otherwise acquire any authorized but unissued shares of the Your capital stock or other of Your securities. 
 Except
as set forth in Your Amended and Restated Investor’s Rights Agreement dated as of July 13, 2007 (the “Investors’ Rights Agreement”), a true, correct and complete copy of which has been delivered to Us prior to the issuance
of this Warrant, Your stockholders do not have preemptive rights to purchase new issuances of Your capital stock. 
  

	•	 	Other Commitments to Register Securities. Except as set forth in this Warrant Agreement and the Investors’ Rights Agreement, You are not, pursuant to the terms of any other agreement currently in existence, under
any obligation to register under the 1933 Act any of Your presently outstanding securities or any of Your securities which may hereafter be issued. 

  

	•	 	Exempt Transaction. Subject to the accuracy of Our representations in Section 7 hereof, the issuance of the Warrant Stock upon exercise of this Warrant Agreement will constitute a transaction exempt from
(i) the registration requirements of Section 5 of the 1933 Act, in reliance upon Section 4(2) thereof, and (ii) the qualification requirements of the applicable state securities laws. 

 

	•	 	Compliance with Rule 144. We may sell the Warrant Stock issuable hereunder in compliance with Rule 144 promulgated by the Securities and Exchange Commission. Within ten (10) days of Our request, You agree to
furnish Us, a written statement confirming Your compliance with the filing requirements of the Securities and Exchange Commission as set forth in such Rule 144, as may be amended. 

 

	•	 	No Impairment. You agree not to, by amendment of Your Certificate of Incorporation or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this Warrant by You, but shall at all times in good faith assist in carrying out of all the provisions of this Warrant and in taking
all such action as may be necessary or appropriate to protect Our rights under this Warrant against impairment. However, You shall not be deemed to have impaired Our rights if You amend Your Certificate of Incorporation, or the holders of Your
preferred stock waiver their rights thereunder, in a manner that does not (individually or when considered in the context of any other actions being taken in connection with such amendments or waivers) affect Us in a manner different from the effect
that such amendments or waivers have on the rights of other holders of the same series and class as the Warrant Stock. 

  

	7.	OUR REPRESENTATIONS AND COVENANTS TO YOU. 

  

	•	 	Investment Purpose. The right to acquire Warrant Stock or the Warrant Stock issuable upon exercise of Our rights contained herein and the Common Stock issuable upon conversion will be acquired for investment purposes
and not with a view to the sale or distribution of any part thereof, and We have no present intention of selling or engaging in any public distribution of the same in violation of the 1933 Act. 

  
 -6- 

	•	 	Private Issue. We understand (i) that this Warrant Agreement, the Warrant Stock issuable upon exercise of this Warrant Agreement and the Common Stock issuable upon conversion of the Warrant Stock are not registered
under the 1933 Act or qualified under applicable state securities laws on the ground that the issuance contemplated by this Warrant Agreement will be exempt from the registration and qualifications requirements thereof, and (ii) that Your
reliance on such exemption is predicated on the representations set forth in this Section 7. 

  

	•	 	Disposition of Our Rights. In no event will We make a disposition of any of Our rights to acquire Warrant Stock or Warrant Stock issuable upon exercise of such rights or the Common Stock issuable upon conversion of the
Warrant Stock unless and until (i) We shall have notified You in writing of the proposed disposition, and (ii) the transferee agrees to be bound in writing to the applicable terms and conditions of this Warrant Agreement, and (iii) if
You request, We shall have furnished You with an opinion of counsel satisfactory to You and Your counsel to the effect that (A) appropriate action necessary for compliance with the 1933 Act has been taken, or (B) an exemption from the
registration requirements of the 1933 Act is available. Notwithstanding the foregoing, the restrictions imposed upon the transferability of any of Our rights to acquire Warrant Stock or Warrant Stock issuable on the exercise of such rights or the
Common Stock issuable upon conversion of the Warrant Stock do not apply to transfers from the beneficial owner of any of the aforementioned securities to its nominee or from such nominee to its beneficial owner, and shall terminate as to any
particular share of Warrant Stock when (1) such security shall have been effectively registered under the 1933 Act and sold by the holder thereof in accordance with such registration or (2) such security shall have been sold without
registration in compliance with Rule 144 under the 1933 Act, or (3) a letter shall have been issued to You at Our request by the staff of the Securities and Exchange Commission or a ruling shall have been issued to You at Our request by such
Commission stating that no action shall be recommended by such staff or taken by such Commission, as the ease may be, if such security is transferred without registration under the 1933 Act in accordance with the conditions set forth in such letter
or ruling and such letter or ruling specifies that no subsequent restrictions on transfer are required. Whenever the restrictions imposed hereunder shall terminate, as hereinabove provided, the holder of a share of Warrant Stock then outstanding as
to which such restrictions have terminated shall be entitled to receive from You, without expense to such holder, one or more new certificates for the Warrant or for such shares of Warrant Stock not bearing any restrictive legend referring to 1933
Act registration or exemption. 

  

	•	 	Financial Risk. We have such knowledge and experience in financial and business matters and knowledge of Your business affairs and financial condition as to be capable of evaluating the merits and risks of Our
investment, and have the ability to bear the economic risks of Our investment. 

  

	•	 	Risk of No Registration. We understand that if You do not register with the Securities and Exchange Commission pursuant to Section 12 of the 1934 Act (the “1934 Act”), or file reports pursuant to
Section 15(d), of the 1934 Act, or if a registration statement covering the securities under the 1933 Act is not in effect when We desire to sell (i) the rights to purchase Warrant Stock pursuant to this Warrant Agreement, or (ii) the
Warrant Stock issuable upon exercise of the right to purchase, or (iii) the Common Stock issuable upon conversion of the Warrant Stock, We may be required to hold such securities for an indefinite period. We also understand that any sale of Our
right to purchase Warrant Stock or Warrant Stock or Common Stock issuable upon conversion of the Warrant Stock, which might be made by it in reliance upon Rule 144 under the 1933 Act may be made only in accordance with the terms and conditions of
that Rule. 

  

	•	 	Accredited Investor. We are an “accredited investor” within the meaning of the Securities and Exchange Rule 501 of Regulation D of the 1933 Act, as presently in effect. 

 

	8.	NOTICES YOU AGREE TO PROVIDE US. 

 You agree to give Us at least twenty (20) days prior written notice of
the following events: 
  

	•	 	If You Pay a Dividend or distribution declaration upon your stock. 

  
 -7- 

	•	 	If You offer for subscription pro-rata to all existing shareholders additional stock or other rights. 

  

	•	 	If You consummate or sign definitive documents providing for a Merger Event. 

  

	•	 	If You have an IPO. 

  

	•	 	If You dissolve or liquidate. 

 All notices in this Section must set forth details of the event, how the event
adjusts either Our number of shares or Our Exercise Price and the method used for such adjustment. 
 Timely Notice. Your failure to timely provide such
notice required above shall entitle Us to retain the benefit of the applicable notice period notwithstanding anything to the contrary contained in any insufficient notice received by Us. 

 

	9.	DOCUMENTS YOU WILL PROVIDE US. 

  

	•	 	Certified Resolutions 

  

	•	 	Certificate of incorporation 

  

	•	 	Investor’s Rights Agreement 

  

	•	 	Bylaws 

  

	•	 	Other documents as We may from time to time reasonably request. 

  

	10.	REGISTRATION RIGHTS UNDER THE 1933 ACT. 

 The holder of this Warrant Agreement shall become party to the
Investor Rights Agreement in effect on the Effective Date for the purposes of being granted certain “S-3” and “Piggyback” registration rights with respect to the common stock issuable upon the conversion of the Warrant Stock.

  

	11.	Market Standoff 

 We hereby agree that, in connection with your initial public offering, we shall not offer,
pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any of Your
securities or enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of Your securities held by us without the prior written consent of You or the
underwriters of Your securities, as the case may be, for a period of one hundred eighty (180) days from the effective date of a registration statement filed under the 1933 Act, provided, that all of your officers and directors and holders of at
least one percent (1%) of Your outstanding voting securities enter into similar agreements (the “Market Standoff’). We agree to execute and deliver such other agreements as may be reasonably requested by You or the underwriter which
are consistent with the foregoing or which are necessary to give further effect thereto. The foregoing provisions of this Section 11 shall apply only to your initial public offering and shall not apply to the sale of any shares to an underwriter
pursuant to an underwriting agreement. We agree that the underwriters in connection with your initial public offering are intended third-party beneficiaries of this Section 11 and shall have the right, power and authority to enforce the
provisions hereof as though they were a party hereto. 
  

	12.	OTHER LEGAL PROVISIONS THE PARTIES WILL ABIDE BY. 

 No Stockholder Rights. This Warrant Agreement does not
entitle Us, or any other holders hereof, to any voting rights or other rights as a stockholder of the Company prior to the exercise hereof. 

  
 -8- 

 Effective Date. This Warrant Agreement shall be construed and shall be given effect in all respects as if it had
been executed and delivered by the Parties on the date hereof. This Warrant Agreement shall be binding upon any of the successors or assigns of the Parties. 

Attorney’s Fees. In any litigation, arbitration or court proceeding between the Parties relating to this Warrant Agreement, the prevailing party shall be
entitled to attorneys’ fees and expenses and all costs of proceedings incurred in enforcing this Warrant Agreement. 
 Governing Law. This Warrant
Agreement shall be governed by and construed for all purposes under and in accordance with the laws of the State of California without giving effect to that body of law pertaining to conflicts of laws. 

Consent to Jurisdiction and Venue. All judicial proceedings arising in or under or related to this Warrant Agreement may be brought in any state or federal
court of competent jurisdiction located in the State of California. By execution and delivery of this agreement, each party hereto generally and unconditionally: (a) consents to personal jurisdiction in San Mateo County, State of California;
(b) waives any objection as to jurisdiction or venue in San Mateo County, State of California; (c) agrees not to assert any defense based on lack of jurisdiction or venue in the aforesaid courts; and (d) irrevocably agrees to be bound
by any judgment rendered thereby in connection with this Plain English Warrant Agreement. Service of process on any party hereto in any action arising out of or relating to this agreement shall be effective if given in accordance with the
requirements for notice set forth in this Section, and shall be deemed effective and received as set forth therein. Nothing herein shall affect the right to serve process in any other manner permitted by law or shall limit the right of either party
to bring proceedings in the courts of any other jurisdiction. 
 Mutual Waiver of Jury Trial; Judicial Reference. Because disputes arising in connection
with complex financial transactions are most quickly and economically resolved by an experienced and expert person and The Parties wish applicable state and federal laws to apply (rather than arbitration rules), The Parties desire that their
disputes be resolved by a judge applying such applicable laws. EACH OF THE PARTIES SPECIFICALLY WAIVES ANY RIGHT THEY MAY HAVE TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, CROSS-CLAIM, COUNTERCLAIM, THIRD PARTY CLAIM OR ANY OTHER CLAIM
(COLLECTIVELY, “CLAIMS”) ASSERTED BY YOU AGAINST US OR OUR ASSIGNEE OR BY US OR OUR ASSIGNEE AGAINST YOU. IN THE EVENT THAT THE FOREGOING JURY TRIAL WAIVER IS NOT ENFORCEABLE, ALL CLAIMS, INCLUDING ANY AND ALL QUESTIONS OF LAW OR
FACT RELATING THERETO, SHALL, AT THE WRITTEN REQUEST OF ANY PARTY, BE DETERMINED BY JUDICIAL REFERENCE PURSUANT TO THE CALIFORNIA CODE OF CIVIL PROCEDURE (“REFERENCE”). THE PARTIES SHALL SELECT A SINGLE NEUTRAL REFEREE, WHO SHALL BE A
RETIRED STATE OR FEDERAL JUDGE. IN THE EVENT THAT THE PARTIES CANNOT AGREE UPON A REFEREE, THE REFEREE SHALL BE APPOINTED BY THE COURT. THE REFEREE SHALL REPORT A STATEMENT OF DECISION TO THE COURT. NOTHING IN THIS SECTION SHALL LIMIT THE RIGHT OF
ANY PARTY AT ANY TIME TO EXERCISE LAWFUL SELF-HELP REMEDIES, FORECLOSE AGAINST COLLATERAL OR OBTAIN PROVISIONAL REMEDIES. THE PARTIES SHALL BEAR THE FEES AND EXPENSES OF THE REFEREE EQUALLY UNLESS THE REFEREE ORDERS OTHERWISE. THE REFEREE SHALL ALSO
DETERMINE ALL ISSUES RELATING TO THE APPLICABILITY, INTERPRETATION, AND ENFORCEABILITY OF THIS SECTION. THE PARTIES ACKNOWLEDGE THAT THE CLAIMS WILL NOT BE ADJUDICATED BY A JURY. This waiver extends to all such Claims, including Claims that involve
Persons other than You and Us; Claims that arise out of or are in any way connected to the relationship between You and Us; and any Claims for damages, breach of contract, specific performance, or any equitable or legal relief of any kind, arising
out of this Warrant Agreement. 
 Counterparts. This Warrant Agreement may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. 
 Notices. Any notice required or permitted under this Warrant Agreement
shall be given in writing and shall be deemed effectively given upon the earlier of (1) actual receipt or 3 days after mailing if mailed postage prepaid by regular or airmail to Us or You or (2) one day after it is sent by overnight mail
via nationally recognized courier or (3) on the same day as sent via confirmed facsimile transmission, provided that the original is sent by personal delivery or mail by the sending party. 

  
 -9- 

 Remedies. In the event of any default hereunder, the non-defaulting party may proceed to protect and enforce its
rights either by suit in equity and/or by action at law, including but not limited to an action for damages as a result of any such default, and/or an action for specific performance for any default where such party will not have an adequate remedy
at law and where damages will not be readily ascertainable. Each party expressly acknowledges and agrees that there is no adequate remedy at law for any breach of this Warrant Agreement and that in the event of any breach of this Agreement, the
injured party shall be entitled to specific performance of any or all provisions hereof or an injunction prohibiting the other party from continuing to commit any such breach of this Agreement. 

Survival. The representations, warranties, covenants, and conditions of the Parties contained herein or made pursuant to this Warrant Agreement shall survive
the execution and delivery of this Warrant Agreement. 
 Severability. In the event any one or more of the provisions of this Warrant Agreement shall for
any reason be held invalid, illegal or unenforceable, the remaining provisions of this Warrant Agreement shall be unimpaired, and the invalid, illegal or unenforceable provision shall be replaced by a mutually acceptable valid, legal and enforceable
provision, which comes closest to the intention of the parties underlying the invalid, illegal or unenforceable provision. 
 Entire Agreement. This Warrant
Agreement constitutes the entire agreement between the Parties pertaining to the subject matter contained in it and supersedes all prior and contemporaneous agreements, representations and undertakings of the Parties, whether oral or written, with
respect to such subject matter. 
 Amendments. Any provision of this Warrant Agreement may only be amended by a written instrument signed by the Parties.

 Lost Warrants or Stock Certificates. You covenant to Us that, upon receipt of evidence reasonably satisfactory to Us of the loss, theft, destruction or
mutilation of this Warrant Agreement or any stock certificate and, in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to You, or in the case of any such mutilation upon surrender and cancellation
of such Warrant Agreement or stock certificate, You will make and deliver a new Warrant Agreement or stock certificate, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant Agreement or stack certificate. 

Rights as Stockholders. We shall not, as a party to this Warrant Agreement, be entitled to vote or receive dividends or be deemed the holder of Series B
Preferred Stock or any of Your other securities which may at any time be issuable upon the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon Us any of the rights of one of Your stockholders or any right
to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to receive dividends or subscription rights or otherwise until this Warrant Agreement is exercised and the shares purchasable upon the
exercise hereof shall have become deliverable, as provided herein. 
 Facsimile Signatures. This Warrant Agreement may be executed and delivered by
facsimile and upon such delivery the facsimile signature will be deemed to have the same effect as if the original signature had been delivered to the other party. 

(Signature Page to Follow) 

  
 -10- 

 IN WITNESS WHEREOF, each of the Parties have caused this Warrant Agreement to be executed by its officers who are
duly authorized as of the Effective Date. 
  

			
	You: AEROHIVE NETWORKS, INC.
		
	Signature:	 	 /s/ David Flynn

	Print Name:	 	David Flynn
	Title:	 	CEO & President
	
	Us: TRIPLEPOINT CAPITAL LLC
		
	Signature:	 	 /s/ Sajal Srivastava

	Print Name:	 	Sajal Srivastava
	Title:	 	Chief Operating Officer

  
 -11- 

 EXHIBIT I 

NOTICE OF EXERCISE 
  

	To:	AEROHIVE NETWORKS, INC. 

  

	1.	We hereby elect to purchase [    ] shares of the Series [    ] Preferred Stock of AEROHIVE NETWORKS, INC., pursuant to the terms of the Plain English Warrant Agreement dated the
[    ] day of [    ], [200    ] (the “Plain English Warrant Agreement”) between You and Us, We hereby tender here payment of the purchase price for such shares in full, together
with all applicable transfer taxes, if any. 

  

	2.	Method of Exercise (Please initial the applicable blank) 

  

	 	a.	         The undersigned elects to exercise the Plain English Warrant Agreement by means of a cash payment, and gives You full payment for the purchase price of the shares
being purchased, together with all applicable transfer taxes, if any. 

  

	 	b.	         The undersigned elects to exercise the Plain English Warrant Agreement by means of the Net Issuance Exercise method of Section 3 of the Plain English Warrant
Agreement. 

  

	3.	In exercising Our rights to purchase the Series B Preferred Stock of AEROHIVE NETWORKS, INC., We hereby confirm and acknowledge the investment representations, warranties and covenants made in Section 7 of the
Plain English Warrant Agreement. 

 Please issue a certificate or certificates representing these purchased shares of Series
[    ] Preferred Stock in Our name or in such other name as is specified below. 
  

			
	  
 (Name)

	
	  
 (Address)

	
	US: TRIPLEPOINT CAPITAL LLC
		
	By:	 	  

		
	Title:	 	  

		
	Date:	 	  

  
 -12- 

 EXHIBIT II 

ACKNOWLEDGMENT OF EXERCISE 
 AEROHIVE NETWORKS,
INC., hereby acknowledges receipt of the “Notice of Exercise” from TRIPLEPO1NT CAPITAL LLC, to purchase [    ] shares of the Series [    ] Preferred Stock of
[            ], pursuant to the terms of the Plain English Warrant Agreement, and further acknowledges that [    ] shares remain subject to purchase under the terms of
the Plain English Warrant Agreement. 
  

							
	 YOU:
	 		 	AEROHIVE NETWORKS, INC.
				
		 		 	By:	 	  

				
		 		 	Title:	 	  

				
		 		 	Date:	 	  

  
 -13- 

 EXHIBIT III 

TRANSFER NOTICE 
 FOR VALUE RECEIVED, the
foregoing Plain English Warrant Agreement and all rights evidenced thereby are hereby transferred and assigned to 
  

			
	  
	 	
	(Please Print)	 	

  

					
	Whose address is	 	  
	 	
		
	  
	 	

  

					
	Dated:	 	  
	  	
			
	Holder’s Signature:	 	  
	  	
			
	Holder’s Address:	 	  
	  	
			
	Transferee’s Signature:	 	  
	  	
			
	Transferee’s Address:	 	  
	  	
			
	Signature Guaranteed:	 	  
	  	

 NOTE: The signature to this Transfer Notice must correspond with the name as it appears on the face of the Plain English
Warrant Agreement, without alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Plain English
Warrant Agreement. 

  
 -14-EX-4.4

 Exhibit 4.4 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED (the “1933 ACT), OR
ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO YOU THAT SUCH REGISTRATION IS NOT
REQUIRED UNDER THE 1933 ACT, OR ANY APPLICABLE STATE SECURITIES LAWS. 
 PLAIN ENGLISH WARRANT AGREEMENT 

This is a PLAIN ENGLISH WARRANT AGREEMENT dated October 9, 2009 by and between AEROHIVE NETWORKS. INC., and TRIPLEPOINT CAPITAL LLC, a Delaware
limited liability company. 
 The words “We”, “Us”, or “Our” refer to the warrant holder, which is TRIPLEPOINT CAPITAL LLC.
The words “You” or “Your” refers to the issuer, which is AEROHIVE NETWORKS, INC., and not to any individual. The words “The Parties” refers to both TRIPLEPOINT CAPITAL LLC and AEROHIVE NETWORKS, INC. This Plain English
Warrant Agreement may be referred to as the “Warrant Agreement.” 
 The Parties have entered into a Plain English Growth Capital Loan and Security
Agreement dated as of March 27, 2008, and First Amendment to Plain English Growth Capital Loan and Security Agreement dated October 9, 2009 (collectively, the “Loan Agreement”). 

In consideration of such Loan Agreement, the Parties agree to the following mutual agreements and conditions set forth below: 

WARRANT INFORMATION 
  

					
	 Effective Date
	  	 Warrant Number
	  	 Loan Facility Number

			
	October 9, 2009	  	0532-W-02	  	0532-GC-02

  

							
	 Warrant Coverage
	  	 Number of Shares
	  	 Price Per Share
	  	 Type of Stock

				
	 $120,102.54 (3% of
$4,003,418.08) subject to the

increase or decrease as set forth in

Section 1 of this
Warrant Agreement.
	  	 74, 009, subject to
the increase or decrease as set

forth in Section 1 of this
Warrant Agreement
	  	 $1.6228, subject to
adjustment as set forth in

this agreement.
	  	 Series B Preferred Stock,

subject to adjustment as set
 forth
in this Warrant
 Agreement.

 OUR CONTACT INFORMATION 

 

					
	 Name
	  	 Address For Notices
	  	 Contact Person

			
	TriplePoint Capital LLC	  	2755 Sand Hill Road, Ste. 150
Menlo Park, CA 94025
Tel: (650) 854-2090 
Fax: (650) 854-1850	  	Sajal Srivastava, COO 

 YOUR
CONTACT INFORMATION 
  

					
	 Customer Name
	  	 Address For Notices
	  	 Contact Person

			
	Aerohive Networks, Inc.	  	3150-C Coronado Drive
Santa Clara, CA 95054	  	Samy Saleh, CFO 

  

	1.	WHAT YOU AGREE TO GRANT US 

  

Initial Grant. You grant to Us and We are entitled, upon the terms and subject to the conditions set forth in this Warrant Agreement, to purchase from
You 74,009 (the “Number of Shares”) fully paid and non-assessable shares of Your Warrant Stock at a purchase price equal to the Exercise Price. 

Increase of Grant. In the event You elect the Adjustment Option 1 under the Loan Agreement in compliance with the relevant provisions of the Loan
Agreement, subject to the conditions set forth in this Warrant Agreement, the Number of Shares shall be increased by 74,009 to 148,018. 
 Decrease of
Grant. In the event You elect the Adjustment Option 2 under the Loan Agreement in compliance with the relevant provisions of the Loan Agreement, subject to the conditions set forth in this Warrant Agreement, the Number of Shares shall be
decreased by 24,669 to 49,340. 
 The Number of Shares of Warrant Stock and the Exercise Price of such Warrant Stock are subject to adjustment as provided
in Section 4 hereof. 
 For purposes of this Warrant Agreement, the following capitalized terms have the meanings given below: 

For purposes of this Warrant Agreement, the following capitalized terms have the meanings given below: 

“Exercise Price” means the lower of (a) $1.6228 and (b) the lowest per share price for which Your preferred stock is sold
in the Next Round. 
 “Next Round” means the next bona fide round of equity financing in which You issue and sell shares of your
preferred stock for aggregate gross cash proceeds of at least $1,000,000 (excluding any amounts received upon conversion or cancellation of indebtedness) subsequent to the Effective Date. 

“Warrant Stock” means (a) the class and series of Your preferred stock issued in the Next Round, if the lowest per share price
for which such preferred stock is sold in the Next Round is less than $1.6228 or (b) in all other cases, Your Series B Preferred Stock. For avoidance of doubt, if this Warrant Agreement is exercised prior to the Next Round then this
Warrant Agreement shall be exercisable for Your Series B Preferred Stock. 
 The Parties agree that this Warrant Agreement to purchase the Warrant
Stock has a fair market value equal to $100 and that $100 of the issue price of the investment will be allocable to the Warrant Agreement and the balance shall be allocable to the Loan Agreement for income tax purposes and the original issue
discount on the Loan Agreement shall be considered to be zero. 
  
  

	2.	WHEN ARE WE ENTITLED TO PURCHASE YOUR WARRANT STOCK. 

  

The term of this Warrant Agreement and our right to purchase Warrant Stock will begin the Effective Date, and shall be available for the lesser of (i) 10
years from the Effective Date or (ii) 1 year from the effective date of Your initial public offering. 
 Notwithstanding the foregoing, Our right to
purchase the Warrant Stock shall be automatically and fully exercised via the net issuance method described below immediately prior to the effectiveness of a Merger Event, as defined below, with a Person that is not one of Your affiliates, in which
Your common stock is exchanged for cash and/or stock that is traded on a recognized public exchange or on the NASDAQ National Market, provided that upon consummation of the Merger Event, the consideration payable to Us pursuant to such exercise and
on account of the Warrant Stock consists of (x) cash or (y) stock that is traded on a recognized public exchange or on the NASDAQ National Market and the total per share consideration is equal to or greater than two (2) times the
aggregate Exercise Price (as adjusted). In the event the stock consideration to be paid in (y) above is less than two (2) times the aggregate Exercise Price (as adjusted) and We have not elected to exercise Our rights under this Warrant
Agreement, then You may, at Your sole discretion, pay Us a sum equal to one (1) time the Exercise Price for each share exercisable under this Warrant Agreement in exchange for the cancellation of this Warrant Agreement upon the consummation of
such Merger Event. 

  
 -2- 

 No less than ten (10) business days prior to any Merger Event, You shall provide Us with written notice of
the proposed Merger Event together with a copy of the executed merger agreement, or other definitive documentation (and all schedules and exhibits thereto) and information concerning Your expected capitalization immediately prior to the Merger
Event. 
 Upon consummation of the Merger Event, You shall promptly provide Us with (a) a copy of any modifications or amendments to the executed
merger agreement, (b) any other documents in connection therewith, (c) updated information, if any, concerning Your capitalization immediately prior to the Merger Event, and, (d) upon request, by Us any other information reasonably
necessary to an informed evaluation of Our rights under this Agreement. 
  

 

	3.	HOW WE MAY PURCHASE YOUR WARRANT STOCK. 

  

We may exercise Our purchase rights, in whole or in part, at any time, or from time to time, prior to the expiration of the term of this Warrant Agreement, by
giving You a completed and executed Notice of Exercise in the form attached as Exhibit I. Promptly upon receipt of the Notice of Exercise and in any event no later than twenty-one (21) days after you have received Our Notice of
Exercise and payment of the aggregate Exercise Price for the shares purchased, You will issue to Us a certificate for the number of shares of Warrant Stock that We have purchased and You will execute the Acknowledgment of Exercise in the form
attached hereto as Exhibit II indicating the number of shares which will be available to Us for future purchases, if any. 
 We may pay for the
Warrant Stock by either (i) cash or check, or (ii) by the net issuance method as determined below. If We elect the Net Issuance method, You will issue Warrant Stock using the following formula: 

 

									
		 	X	  	=	  	Y(A-B)	  	
		 		  		  	A	  	

  

					
	Where:	  	X =	  	the number of shares of Warrant Stock to be issued to Us.
		  	Y =	  	the number of shares of Warrant Stock We request to be exercised under this Warrant Agreement.
		  	A =	  	the fair market value of one share of Warrant Stock.
		  	B =	  	the Exercise Price.

 For purposes of the above calculation, current fair market value of Warrant Stock shall mean with respect to each share of
Warrant Stock: 
 If the exercise is in connection with the initial public offering of Your Common Stock, and if Your registration statement relating
to such public offering has been declared effective by the SEC, then the fair market value per share shall be the product of (x) the initial “Price to Public” specified in the final prospectus of the offering and (y) the number
of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise; 
 If this Warrant Agreement is exercised
after, and not in connection with the Your initial public offering, and: 
  

	•	 	if traded on a securities exchange, the fair market value shall be the product of (x) the average of the closing prices over a five (5) day period ending three (3) days before the day the current fair
market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise; or 

 

	•	 	if actively traded over-the-counter, the fair market value shall be the product of (x) the average of the closing bid and asked prices quoted on the NASDAQ system (or similar system) over the five (5) day
period ending three (3) days before the day the current fair market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such
exercise. 

 If this Warrant Agreement is exercised prior to or after Your initial public offering, and: 

 

	•	 	 Your Common Stock is not listed on any securities exchange or quoted in the NASDAQ System or the over-the-counter market, the current fair market
value of Warrant Stock shall be the product of (x) the fair market value of a 

  
 -3- 

	 	 
share of Your Common Stock (the highest price per share which You could obtain from a willing buyer (not a current employee or director) for shares of Common Stock sold, from authorized but
unissued shares), as determined in good faith by Your Board of Directors and (y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise, unless You shall become subject to a
merger, acquisition or other consolidation pursuant to which You are not the surviving party, in which case the fair market value of Warrant Stock shall be deemed to be the value received by the holders of the Your Warrant Stock on a common
equivalent basis pursuant to such merger or acquisition or other consolidation. 

 During the term of this Warrant Agreement, You will at
all times from and after the Effective Date have authorized and reserved a sufficient number of shares of (a) Warrant Stock to provide for the exercise of our rights to purchase Warrant Stock, and (b) Common Stock to provide for the
conversion of the Warrant Stock. 
 If We elect to exercise part of the Warrant Agreement, You will promptly issue to Us an amended Warrant Agreement
stating the remaining number of shares that are available. All other terms and conditions of that amended Warrant Agreement shall be identical to those contained in this Warrant Agreement. 

If at the end of the term of this Warrant Agreement, the fair market value of one share of Warrant Stock (or other security issuable upon the exercise hereof)
as determined in accordance herewith is greater than the Exercise Price in effect on such date, then this Warrant Agreement shall automatically be deemed on and as of such date to be converted via the net issuance method described hereto as to all
shares of Warrant Stock (or such other securities) for which it shall not previously have been exercised or converted, and You shall promptly deliver a certificate representing the shares of Warrant Stock (or such other securities) issued upon such
conversion to Us. 
  
  

	4.	WHEN WILL THE NUMBER OF SHARES AND EXERCISE PRICE CHANGE. 

  

 

	•	 	If You are Acquired. Subject to Section 2 hereto, if at any time: (i) there is a reorganization of Your stock (other than a reclassification, exchange or subdivision of Your stock otherwise provided for
in this Warrant Agreement); (ii) You merge or consolidate with or into another entity, whether or not You are the surviving entity; (iii) You sell or convey, or grant an exclusive license with respect to, all or substantially all of Your
assets to any other person; or (iv) there occurs any transaction or series of related transactions that result in the transfer of fifty percent (50%) or more of the outstanding voting power of the capital stock of You (each of the
foregoing events are referred to as a “Merger Event”), then, as a part of such Merger Event, lawful provision shall be made so that We shall thereafter be entitled to receive, upon exercise of Our rights under this Warrant Agreement, the
number of shares of preferred stock or other securities of the successor or surviving person resulting from such Merger Event, equal in value to that which would have been issuable if We had exercised Our rights under this Warrant Agreement
immediately prior to the Merger Event. In any such case, appropriate adjustment (as determined in good faith by the Your Board of Directors) shall be made in the application of the provisions of this Warrant Agreement with respect to Our rights and
interest after the Merger Event so that the provisions of this Warrant Agreement (including adjustments of the Exercise Price and number of shares of Warrant Stock purchasable) shall be applicable to the greatest extent possible. 

 

	•	 	If You Reclassify Your Stock. If at any time You combine, reclassify, exchange or subdivide Your securities or otherwise, change any of the securities as to which purchase rights under this Warrant
Agreement exist into the same or a different number of securities of any other class or classes, this Warrant Agreement will thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of
such change with respect to the securities which were subject to the purchase rights under this Warrant Agreement immediately prior to such combination, reclassification, exchange, subdivision or other change. 

 

	•	 	If You Subdivide or Combine Your Shares. If at any time You combine or subdivide Your Series B Preferred Stock, the Exercise Price will be proportionately decreased in the case of a subdivision, or
proportionately increased in the case of a combination. 

  

	•	 	 If You Pay Stock Dividends. If at any time You pay a dividend payable in, or make any other distribution (except any distribution specifically
provided for in the above paragraphs) of Your Series B Preferred Stock, then the Exercise Price shall be adjusted, from and after the record date of such dividend or distribution, to that price determined by multiplying the Exercise Price in
effect immediately prior to such record date by a fraction (i) the numerator of which shall be the total number of all shares of Your Series B Preferred Stock outstanding immediately

  
 -4- 

	 	 
prior to such dividend or distribution, and (ii) the denominator of which shall be the total number of all shares of Your Series B Preferred Stock outstanding immediately after such
dividend or distribution. We will thereafter be entitled to purchase, at the Exercise Price resulting from such adjustment, the number of shares of Warrant Stock (calculated to the nearest whole share) obtained by multiplying the Exercise Price in
effect immediately prior to such adjustment by the number of shares of Warrant Stock issuable upon the exercise hereof immediately prior to such adjustment and dividing the product thereof by the Exercise Price resulting from such adjustment.

  

	•	 	If You Change the Antidilution Rights of the Warrant Stock or Issue New Preferred or Convertible Stock. All antidilution rights applicable to the Warrant Stock purchasable under this Warrant Agreement are as set
forth in Your Certificate of Incorporation, as amended through the Effective Date. You will promptly provide Us with any restatement, amendment, modification of or waiver of any right under Your Certificate of Incorporation. You will provide Us with
prior written notice of any issuance of Your stock or other equity security to occur after the Effective Date (other than issuances of stock or equity securities pursuant to customary employee stock plans), which notice shall include (a) the
price at which such stock or security is to be sold, (b) the number of shares to be issued, and (c) such other information as necessary for Us to determine if a dilutive event has occurred or will occur as a result of such issuance.

  

	•	 	No Duplication of Adjustments. Notwithstanding anything to the contrary in this Warrant, nothing in this Warrant shall be deemed to duplicate adjustments to the number of Shares of Warrant stock issuable pursuant
to this Warrant, or the exercise price thereof, to the extent of adjustments made to stock of the same class and series as the Warrant Stock generally pursuant to the Company’s Certificate of Incorporation, as may be in effect from time to
time. 

  

	•	 	No Fractional Shares. We acknowledge that You will not issue fractional shares upon the exercise of this Warrant Agreement, in lieu of such fractional shares You will make a cash payment on the basis of the
Exercise Price then in effect. 

  
  

	5.	WE CAN TRANSFER THIS PLAIN ENGLISH WARRANT AGREEMENT. 

  

Subject to the terms and conditions contained in Section 7, We (or any successor transferee) may transfer in whole or in part this Warrant Agreement and
all its rights. You will record the transfer on Your books when You receive Our Notice of Transfer in the form attached hereto as Exhibit III, and Our payment of all transfer taxes and other governmental charges involved in such
transfer, 
  
  

	6.	REPRESENTATIONS, WARRANTIES, AND COVENANTS FROM YOU. 

  

 

	•	 	Reservation of Warrant Stock. The Warrant Stock issuable upon exercise of Our rights under this Warrant Agreement will be duly and validly reserved and when issued in accordance with the provisions of this
Warrant Agreement will be validly issued, fully paid and non-assessable, and will be free of any taxes, liens, charges or encumbrances of any nature whatsoever; provided, however, that the Warrant Stock issuable pursuant to this Warrant Agreement
may be subject to restrictions on transfer under state and/or Federal securities laws. Upon Our exercise, You will issue to Us certificates for shares of Warrant Stock without charging Us any tax, or other cost incurred by You in connection with
such exercise and the related issuance of shares of Warrant Stock, You will not be required to pay any tax, which may be payable in respect of any transfer involved and the issuance and delivery of any certificate in a name other than TriplePoint
Capital L.L.C. 

  

	•	 	Due Authority. Your execution and delivery of this Warrant Agreement and the performance of Your obligations hereunder, including the issuance to Us of the right to acquire the shares of Warrant Stock, have been
duly authorized by all necessary corporate action on Your part and this Warrant Agreement is not inconsistent with the Your Certificate of Incorporation or Bylaws, does not contravene any law or governmental rule, regulation or order applicable to
it, do not and will not contravene any provision of, or constitute a default under, any indenture, mortgage, contract or other instrument to which You are a party or by which You are bound, and this Warrant Agreement constitutes a legal, valid and
binding agreement, enforceable in accordance with its respective terms, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors and the rules of law or principles at equity governing specific performance,
injunctive relief and other equitable remedies. 

  
 -5- 

	•	 	Consents and Approvals. No consent or approval of, giving of notice to, registration with, or taking of any other action in respect of any state, Federal or other governmental authority or agency is required with
respect to execution, delivery and Your performance of Your obligations under this Warrant Agreement, except for the filing of any required notices pursuant to Federal and state securities laws, which filings will be effective by the times required
thereby. 

  

	•	 	Issued Securities. All of Your issued and outstanding shares of Common Stock, Warrant Stock or any other securities have been duly authorized and validly issued and are fully paid and nonassessable. All
outstanding shares of Common Stock and Warrant Stock were issued in full compliance with all Federal and state securities laws. In addition as of the Effective Date: 

Your authorized capital consists of (A) 43,300,000 shares of Common Stock, of which 12,606,688 shares of Common Stock are issued and outstanding, and
(B) [26.694,720] shares of preferred stock, of which 26,117,480 shares are issued and outstanding. 
 You have reserved 10,300,000 shares of Common
Stock for issuance under Your Stock Incentive Plan, under which options for the purchase of 2,937,675 shares of Common Stock are outstanding and options for the purchase of 892,570 shares of Common Stock are available for grant. You have issued
warrants for the purchase of 413,792 shares of Your Series A Preferred Stock and 98,595 shares of Your Series B Preferred Stock, which remain unexercised and outstanding as of the Effective Date. Except as otherwise provided in this
Warrant Agreement and as noted above, there are no other options, warrants, conversion privileges or other rights presently outstanding to purchase or otherwise acquire any authorized but unissued shares of the Your capital stock or other of Your
securities. 
 Except as set forth in Your Amended and Restated Investor’s Rights Agreement dated as of July 13, 2007 and amended by the Amendment
No. 1 dated as of March 27, 2008 (collectively, the “Investors’ Rights Agreement”), a true, correct and complete copy of which has been delivered to Us prior to the issuance of this Warrant. Your stockholders do not have
preemptive rights to purchase new issuances of Your capital stock. 
  

	•	 	Other Commitments to Register Securities. Except as set forth in this Warrant Agreement and the Investors’ Rights Agreement, You are not, pursuant to the terms of any other agreement currently in existence,
under any obligation to register under the 1933 Act any of Your presently outstanding securities or any of Your securities which may hereafter be issued. 

  

	•	 	Exempt Transaction. Subject to the accuracy of Our representations in Section 7 hereof, the issuance of the Warrant Stock upon exercise of this Warrant Agreement will constitute a transaction exempt from
(i) the registration requirements of Section 5 of the 1933 Act, in reliance upon Section 4(2) thereof, and (ii) the qualification requirements of the applicable state securities laws. 

 

	•	 	Compliance with Rule 144. We may sell the Warrant Stock issuable hereunder in compliance with Rule 144 promulgated by the Securities and Exchange Commission pursuant to Section 2.12 of the
Investors’ Rights Agreement. 

  

	•	 	No Impairment. You agree not to, by amendment of Your Certificate of Incorporation or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this Warrant by You, but shall at all times in good faith assist in carrying out of all the provisions of this Warrant and
in taking all such action as may be necessary or appropriate to protect Our rights under this Warrant against impairment. However, You shall not be deemed to have impaired Our rights if You amend Your Certificate of Incorporation, or the holders of
Your preferred stock waive their rights thereunder, in a manner that does not (individually or when considered in the context of any other actions being taken in connection with such amendments or waivers) affect Us in a manner different from the
effect that such amendments or waivers have on the rights of other holders of the same series and class as the Warrant Stock. 

  
 -6- 

  

	7.	OUR REPRESENTATIONS AND COVENANTS TO YOU. 

  

 

	•	 	Investment Purpose. The right to acquire Warrant Stock or the Warrant Stock issuable upon exercise of Our rights contained herein and the Common Stock issuable upon conversion will be acquired for investment
purposes and not with a view to the sale or distribution of any part thereof, and We have no present intention of selling or engaging in any public distribution of the same in violation of the 1933 Act. 

 

	•	 	Private Issue. We understand (i) that this Warrant Agreement, the Warrant Stock issuable upon exercise of this Warrant Agreement and the Common Stock issuable upon conversion of the Warrant Stock are not
registered under the 1933 Act or qualified under applicable state securities laws on the ground that the issuance contemplated by this Warrant Agreement will be exempt from the registration and qualifications requirements thereof, and (ii) that
Your reliance on such exemption is predicated on the representations set forth in this Section 7. 

  

	•	 	Disposition of Our Rights. In no event will We make a disposition of any of Our rights to acquire Warrant Stock or Warrant Stock issuable upon exercise of such rights or the Common Stock issuable upon conversion
of the Warrant Stock unless and until (i) We shall have notified You in writing of the proposed disposition, and (ii) the transferee agrees to be bound in writing to the applicable terms and conditions of this Warrant Agreement, and
(iii) if You request, We shall have furnished You with an opinion of counsel satisfactory to You and Your counsel to the effect that (A) appropriate action necessary for compliance with the 1933 Act has been taken, or (B) an exemption
from the registration requirements of the 1933 Act is available. Notwithstanding the foregoing, the restrictions imposed upon the transferability of any of Our rights to acquire Warrant Stock or Warrant Stock issuable on the exercise of such rights
or the Common Stock issuable upon conversion of the Warrant Stock do not apply to transfers from the beneficial owner of any of the aforementioned securities to its nominee or from such nominee to its beneficial owner, and shall terminate as to any
particular share of Warrant Stock when (1) such security shall have been effectively registered under the 1933 Act and sold by the holder thereof in accordance with such registration or (2) such security shall have been sold without
registration in compliance with Rule 144 under the 1933 Act, or (3) a letter shall have been issued to You at Our request by the staff of the Securities and Exchange Commission or a ruling shall have been issued to the You at Our request
by such Commission stating that no action shall be recommended by such staff or taken by such Commission, as the case may be, if such security is transferred without registration under the 1933 Act in accordance with the conditions set forth in such
letter or ruling and such letter or ruling specifies that no subsequent restrictions on transfer are required. Whenever the restrictions imposed hereunder shall terminate, as hereinabove provided, the holder of a share of Warrant Stock then
outstanding as to which such restrictions have terminated shall be entitled to receive from You, without expense to such holder, one or more new certificates for the Warrant or for such shares of Warrant Stock not bearing any restrictive legend
referring to 1933 Act registration or exemption. 

  

	•	 	Financial Risk. We have such knowledge and experience in financial and business matters and knowledge of Your business affairs and of the 1933 Act, as presently in effect. 

 

	•	 	Risk of No Registration. We understand that if You do not register with the Securities and Exchange Commission pursuant to Section 12 of the 1934 Act (the “1934 Act”) or file reports pursuant to
Section 15(d), of the 1934 Act, or if a registration statement covering the securities under the 1933 Act is not in effect when We desire to sell (i) the rights to purchase Warrant Stock pursuant to this Warrant Agreement, or (ii) the
Warrant Stock issuable upon exercise of the right to purchase, or (iii) the Common Stock issuable upon conversion of the Warrant Stock, We may be required to hold such securities for an indefinite period. We also understand that any sale of Our
right to purchase Warrant Stock or Warrant Stock or Common Stock issuable upon conversion of the Warrant Stock, which might be made by it in reliance upon Rule 144 under the 1933 Act may be made only in accordance with the terms and conditions of
that Rule. 

  

	•	 	Accredited Investor. We are an “accredited investor” within the meaning of the Securities and Exchange Rule 501 of Regulation D of the 1933 Act, as presently in effect. 

 
  

	8.	NOTICES YOU AGREE TO PROVIDE US. 

  

You agree to give Us at least twenty (20) days prior written notice of the following events: 

 

	•	 	If You Pay a Dividend or distribution declaration upon your stock. 

  

	•	 	if You offer for subscription pro-rata to all existing shareholders additional stock or other rights. 

  
 -7- 

	•	 	If You consummate or sign definitive documents providing for a Merger Event. 

  

	•	 	If You have an IPO. 

  

	•	 	If You dissolve or liquidate. 

 All notices in this Section must set forth details of the event, how the event
adjusts either Our number of shares or Our Exercise Price and the method used for such adjustment. 
 Timely Notice. Your failure to timely provide
such notice required above shall entitle Us to retain the benefit of the applicable notice period notwithstanding anything to the contrary contained in any insufficient notice received by Us. 

 
  

	9.	DOCUMENTS YOU WILL PROVIDE US. 

  

 

	•	 	Certified Resolutions 

  

	•	 	Certificate of Incorporation 

  

	•	 	Investor’s Rights Agreement 

  

	•	 	Bylaws 

  

	•	 	Other documents as We may from time to time reasonably request. 

  

 

	10.	REGISTRATION RIGHTS UNDER THE 1933 ACT. 

  

The holder of this Warrant Agreement shall become a party to the Investor Rights Agreement in effect on the Effective Date for the purposes of being granted
certain “S-3” and “Piggyback” registration rights with respect to the common stock issuable upon the conversion of the Warrant Stock. 

 
  

	11.	Market Standoff 

  

We hereby agree that, in connection with your initial public offering, we shall not offer, pledge, sell, contract to sell, sell any option or contract to
purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any of Your securities or enter into any swap, hedging or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of any of Your securities held by us without the prior written consent of You or the underwriters of Your securities, as the case may be, for a period of one
hundred eighty (180) days from the effective date of a registration statement filed under the 1933 Act, provided, that all of your officers and directors and holders of at least one percent (1%) of Your outstanding voting securities enter
into similar agreements (the “Market Standoff”). We agree to execute and deliver such other agreements as may be reasonably requested by You or the underwriter which are consistent with the foregoing or which are necessary to give further
effect thereto. The foregoing provisions of this Section 11 shall apply only to your initial public offering and shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement. We agree that the underwriters
in connection with your initial public offering are intended third-party beneficiaries of this Section 11 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. 

 
  

	12.	OTHER LEGAL PROVISIONS THE PARTIES WILL ABIDE BY. 

  

No Stockholder Rights. This Warrant Agreement does not entitle Us, or any other holders hereof, to any voting rights or other rights as a stockholder of
the Company prior to the exercise hereof. 

  
 -8- 

 Effective Date. This Warrant Agreement shall be construed and shall be given effect in all respects as if
it had been executed and delivered by the Parties on the date hereof. This Warrant Agreement shall be binding upon any of the successors or assigns of the Parties. 

Attorney’s Fees. In any litigation, arbitration or court proceeding between the Parties relating to this Warrant Agreement, the prevailing party
shall be entitled to attorneys’ fees and expenses and all costs of proceedings incurred in enforcing this Warrant Agreement. 
 Governing Law.
This Warrant Agreement shall be governed by and construed for all purposes under and in accordance with the laws of the State of California without giving effect to that body of law pertaining to conflicts of laws. 

Consent to Jurisdiction and Venue. All judicial proceedings arising in or under or related to this Warrant Agreement may be brought in any state or
federal court of competent jurisdiction located in the State of California. By execution and delivery of this agreement, each party hereto generally and unconditionally: (a) consents to personal jurisdiction in San Mateo County, State of
California; (b) waives any objection as to jurisdiction or venue in San Mateo County, State of California; (c) agrees not to assert any defense based on lack of jurisdiction or venue in the aforesaid courts; and (d) irrevocably agrees
to be bound by any judgment rendered thereby in connection with this Plain English Warrant Agreement. Service of process on any party hereto in any action arising out of or relating to this agreement shall be effective if given in accordance with
the requirements for notice set forth in this Section, and shall be deemed effective and received as set forth therein. Nothing herein shall affect the right to serve process in any other manner permitted by law or shall limit the right of either
party to bring proceedings in the courts of any other jurisdiction. 
 Mutual Waiver of Jury Trial; Judicial Reference. Because disputes arising in
connection with complex financial transactions are most quickly and economically resolved by an experienced and expert person and The Parties wish applicable state and federal laws to apply (rather than arbitration rules), The Parties desire that
their disputes be resolved by a judge applying such applicable laws. EACH OF THE PARTIES SPECIFICALLY WAIVES ANY RIGHT THEY MAY HAVE TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, CROSS-CLAIM, COUNTERCLAIM, THIRD PARTY CLAIM OR ANY OTHER CLAIM
(COLLECTIVELY, “CLAIMS”) ASSERTED BY YOU AGAINST US OR OUR ASSIGNEE OR BY US OR OUR ASSIGNEE AGAINST YOU. IN THE EVENT THAT THE FOREGOING JURY TRIAL WAIVER IS NOT ENFORCEABLE, ALL CLAIMS, INCLUDING ANY AND ALL QUESTIONS OF LAW OR
FACT RELATING THERETO SHALL, AT THE WRITTEN REQUEST OF ANY PARTY, BE DETERMINED BY JUDICIAL REFERENCE PURSUANT TO THE CALIFORNIA CODE OF CIVIL PROCEDURE (“REFERENCE”). THE PARTIES SHALL SELECT A SINGLE NEUTRAL REFEREE, WHO SHALL BE A
RETIRED STATE OR FEDERAL JUDGE. IN THE EVENT THAT THE PARTIES CANNOT AGREE UPON A REFEREE, THE REFEREE SHALL BE APPOINTED BY THE COURT. THE REFEREE SHALL REPORT A STATEMENT OF DECISION TO THE COURT. NOTHING IN THIS SECTION SHALL LIMIT THE RIGHT OF
ANY PARTY AT ANY TIME TO EXERCISE LAWFUL SELF-HELP REMEDIES, FORECLOSE AGAINST COLLATERAL OR OBTAIN PROVISIONAL REMEDIES. THE PARTIES SHALL BEAR THE FEES AND EXPENSES OF THE REFEREE EQUALLY UNLESS THE REFEREE ORDERS OTHERWISE. THE REFEREE SHALL ALSO
DETERMINE ALL ISSUES RELATING TO THE APPLICABILITY, INTERPRETATION, AND ENFORCEABILITY OF THIS SECTION. THE PARTIES ACKNOWLEDGE THAT THE CLAIMS WILL NOT BE ADJUDICATED BY A JURY. This waiver extends to all such Claims, including Claims that involve
Persons other than You and Us; Claims that arise out of or are in any way connected to the relationship between You and Us; and any Claims for damages, breach of contract, specific performance, or any equitable or legal relief of any kind, arising
out of this Warrant Agreement. 
 Counterparts. This Warrant Agreement may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. 
 Notices. Any notice required or permitted under this Warrant
Agreement shall be given in writing and shall be deemed effectively given upon the earlier of (1) actual receipt or 3 days after mailing if mailed postage prepaid by regular or airmail to Us or You or (2) one day after it is sent by
overnight mail via nationally recognized courier or (3) on the same day as sent via confirmed facsimile transmission, provided that the original is sent by personal delivery or mail by the sending party. 

Remedies. In the event of any default hereunder, the non-defaulting party may proceed to protect and enforce its rights either by suit in equity and/or
by action at law, including but not limited to an action for damages as a result of any such 

  
 -9- 

 
default, and/or an action for specific performance for any default where such party will not have an adequate remedy at law and where damages will not be readily ascertainable. Each party
expressly acknowledges and agrees that there is no adequate remedy at law for any breach of this Warrant Agreement and that in the event of any breach of this Agreement, the injured party shall be entitled to specific performance of any or all
provisions hereof or an injunction prohibiting the other party from continuing to commit any such breach of this Agreement. 
 Survival. The
representations, warranties, covenants, and conditions of the Parties contained herein or made pursuant to this Warrant Agreement shall survive the execution and delivery of this Warrant Agreement. 

Severability. In the event any one or more of the provisions of this Warrant Agreement shall for any reason be held invalid, illegal or unenforceable,
the remaining provisions of this Warrant Agreement shall be unimpaired, and the invalid, illegal or unenforceable provision shall be replaced by a mutually acceptable valid, legal and enforceable provision, which comes closest to the intention of
the parties underlying the invalid, illegal or unenforceable provision. 
 Entire Agreement. This Warrant Agreement constitutes the entire agreement
between the Parties pertaining to the subject matter contained in it and supersedes all prior and contemporaneous agreements, representations and undertakings of the Parties, whether oral or written, with respect to such subject matter. 

Amendments. Any provision of this Warrant Agreement may only be amended by a written instrument signed by the Parties. 

Lost Warrants or Stock Certificates. You covenant to Us that, upon receipt of evidence reasonably satisfactory to Us of the loss, theft, destruction or
mutilation of this Warrant Agreement or any stock certificate and, in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to You, or in the case of any such mutilation upon surrender and cancellation
of such Warrant Agreement or stock certificate. You will make and deliver a new Warrant Agreement or stock certificate, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant Agreement or stock certificate. 

Rights as Stockholders. We shall not, as a party to this Warrant Agreement, be entitled to vote or receive dividends or be deemed the holder of
Series B Preferred Stock or any of Your other securities which may at any time be issuable upon the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon Us any of the rights of one of Your
stockholders or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to receive dividends or subscription rights or otherwise until this Warrant Agreement is exercised and the shares
purchasable upon the exercise hereof shall have become deliverable, as provided herein. 
 Facsimile Signatures. This Warrant Agreement may be
executed and delivered by facsimile and upon such delivery the facsimile signature will be deemed to have the same effect as if the original signature had been delivered to the other party. 

(Signature Page to Follow) 

  
 -10- 

 IN WITNESS WHEREOF, each of the Parties have caused this Warrant Agreement to be executed
by its officers who are duly authorized as of the Effective Date. 
  

			
	You: 	 	AEROHIVE NETWORKS, INC.
		
	Signature:	 	 /s/ David Flynn

	Print Name:	 	David Flynn
	Title:	 	CEO
		
	Us: 	 	TRIPLEPOINT CAPITAL LLC
		
	Signature:	 	 /s/ Sajal Srivastava

	Print Name:	 	Sajal Srivastava
	Title:	 	COO

 EXHIBIT I 

NOTICE OF EXERCISE 
  

	To:	AEROHIVE NETWORKS, INC. 

  

	1.	We hereby elect to purchase [                ] shares of the
Series [            ] Preferred Stock of AEROHIVE NETWORKS, INC., pursuant to the terms of the Plain English Warrant Agreement dated the
[        ] day of [            ], [200] (the “Plain English Warrant Agreement”) between You and Us. We hereby tender here payment of the
purchase price for such shares in full, together with all applicable transfer taxes, if any. 

  

	2.	Method of Exercise (Please initial the applicable blank) 

  

	 	(a)	                     The undersigned elects to exercise the Plain English Warrant Agreement by means of a cash payment,
and gives You full payment for the purchase price of the shares being purchased, together with all applicable transfer taxes, if any. 

  

	 	(b)	                     The undersigned elects to exercise the Plain English Warrant Agreement by means of the Net
Issuance Exercise method of Section 3 of the Plain English Warrant Agreement. 

  

	3.	In exercising Our rights to purchase the Series B Preferred Stock of AEROHIVE NETWORKS, INC., We hereby confirm and acknowledge the investment representations, warranties and covenants made in Section 7 of the
Plain English Warrant Agreement. 

 Please issue a certificate or certificates representing these purchased shares of
Series [            ] Preferred Stock in Our name or in such other name as is specified below. 
  

			
	  

	(Name)
	
	  

	(Address)
		
	US: 	 	TRIPLEPOINT CAPITAL LLC
		
	By:	 	  

		
	Title:	 	  

		
	Date:	 	  

 EXHIBIT II 

ACKNOWLEDGMENT OF EXERCISE 
 AEROHIVE
NETWORKS, INC. hereby acknowledges receipt of the “Notice of Exercise” from TRIPLEPOINT CAPITAL LLC to purchase [                ] shares of the
Series [            ] Preferred Stock of [            ], pursuant to the terms of the Plain English Warrant Agreement, and
further acknowledges that [                ] shares remain subject to purchase under the terms of the Plain English Warrant Agreement. 

 

					
	YOU:	 	AEROHIVE NETWORKS, INC.
			
		 	By:	 	  

			
		 	Title:	 	  

			
		 	Date:	 	  

 EXHIBIT III 

TRANSFER NOTICE 
 FOR VALUE
RECEIVED, the foregoing Plain English Warrant Agreement and all rights evidenced thereby are hereby transferred and assigned to 
  

	
	  

	(Please Print)

  

			
	 Whose address is
	  	  

	
	  

 

			
	Dated:	 	  

		
	Holder’s Signature:	 	  

		
	Holder’s Address:	 	  

		
	Transferee’s Signature:	 	  

		
	Transferee’s Address:	 	  

		
	Signature Guaranteed:	 	  

 NOTE: The signature to this Transfer Notice must correspond with the name as it appears on the face of the Plain
English Warrant Agreement, without alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Plain
English Warrant Agreement.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]